Tag Archives: akrx

Qihoo, WuXi, Akorn Among Last IBD 50 Earnings Reports

Sometimes the best is saved for last. Earnings season is winding down, but leaders like Qihoo 360 Technology (QIHU) and Akorn (AKRX) are on tap. They are joined by fellow IBD 50 companies WuXi PharmaTech (WX) and Gentherm (THRM) that are slated to report earnings in the coming week. The IBD 50 lists companies based on superior earnings, strong price performance, and leadership within industries. Akorn, ranked No. 49 on the IBD 50, is slated to

Akorn, Questcor, Parexel Among Top Medical Small Caps

The health care industry is rapidly changing with new advances in medicine. Many of the most promising novel advancements are coming from smaller companies, which are more nimble and quicker to change. Medicine and health care-related stocks Akorn (AKRX), Questcor Pharmaceuticals (QCOR), Parexel International (PRXL), and Medidata Solutions (MDSO) are highly ranked companies featured in the Screen of the Day. The Small-Cap Leaders screen features

Akorn Acquires Eye Drugs From Merck; Stock Hits High

Drugmaker Akorn (AKRX) acquired rights to three eye-drop brands from Merck (MRK) division Inspire Pharmaceuticals Friday, sending Akorn stock to a new high in midday trading on the market. Akorn paid $52.8 million for two variants of glaucoma treatment Cosopt, along with AzaSite for bacterial conjunctivitis. The move added to Akorn’s strategy to become a top player in ophthalmology, which fueled its decision to buy Hi-Tech Pharmacal earlier this